Imaging technologies in urology have become integral tools for diagnosing and treating various urinary and reproductive system conditions. These technologies range from ultrasounds and CT scans to ...

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Serum DR-70 levels are higher in bladder cancer patients, especially in muscle-invasive cases, indicating potential for diagnosis and staging. Current diagnostic methods for bladder cancer are ...

ELIZABETHTON, Tenn.--(BUSINESS WIRE)--I-O Urology Corp., the leading provider of digital diagnostic technologies for remote urologic care, today announced the availability of its CarePath ® platform ...

Out-of-pocket costs for tests used to diagnose prostate cancer have increased in recent years, according to research published in Cancer. Researchers found that out-of-pocket costs for prostate biopsy ...

Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with Mediwatch for urodynamics diagnostic equipment and urology/pelvic floor clinical testing ...

The test, a decade in the making, is being touted by UCSD physicians as addressing "a critical diagnostic gap." ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

A urology expert who was given a prostate cancer diagnosis admitted he initially overlooked two common symptoms of the disease before his diagnosis. Professor Christopher Cheng, who dedicated over ...